BioMed Research International

Review Article

A Meta-Analysis of 13 Randomized Trials on Traditional Chinese Medicine as Adjunctive Therapy for COVID-19: Novel Insights into Lianhua Qingwen

Table 1

The main characteristics of the randomized controlled trials are included in the meta-analysis.
AuthorYearCountryTraditional ChineseSamplePatient average age (y)TCMTreatmentRef.
Medicine (TMC)SizeControlExperimentDosageDuration
Chen et al.2021ChinaLianhua Qingwen capsules604 capsules, bid15 days[12]
Hu et al.2020ChinaLianhua Qingwen capsules2846 g, tid7 days[13]
Yu2020ChinaLianhua Qingwen capsules2954 capsules, tidNot reported[14]
Chen et al.2020ChinaLianhua Qingwen capsules704 capsules, tid14 days[15]
Xiao et al.2020ChinaLianhua Qingwen capsules1216 g, tid14 days[16]
Fu et al.2020ChinaToujie Quwen granules36Not reported, bid10 days[17]
Fu et al.2020ChinaToujie Quwen granules38Not reported, bid15 days[18]
Xiao et al.2020ChinaShufeng Jiedu capsules2002.08 g, tid14 days[19]
Wang et al.2021ChinaQingfei Paidu decoction71100 mL, bid10 days[20]
Li and Zhang2020ChinaQingfei Paidu decoction12100 mL, bidNot reported[21]
Yang et al.2020ChinaReyanning49Not reportedNot reported[22]
Duan et al.2020ChinaJinhua Qinggan granules6210 g, tid5 days[23]
Ding et al.2020ChinaQingfei Touxie Fuzhengfang100150 mL, bid10 days[24]